Nisa Investment Advisors
INO icon

Nisa Investment Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Nisa Investment Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-361
Closed -$735 – 3035
2025
Q2 		$735 Sell
361
-241
-40% -$462 ﹤0.01% 2799
2025
Q1 		$981 Buy
602
+338
+128% +$678 ﹤0.01% 2642
2024
Q4 		$483 Buy
264
+231
+700% +$1.02K ﹤0.01% 2837
2024
Q3 		$191 Buy
+33
New +$272 ﹤0.01% 2858
2023
Q2 		– Sell
-144
Closed -$1K – 2834
2023
Q1 		$1K Buy
144
+7
+5% +$119 ﹤0.01% 2403
2022
Q4 		$3K Hold
137
– – ﹤0.01% 2339
2022
Q3 		$4K Hold
137
– – ﹤0.01% 2320
2022
Q2 		$3K Hold
137
– – ﹤0.01% 2320
2022
Q1 		$6K Sell
137
-490
-78% -$22.1K ﹤0.01% 2286
2021
Q4 		$31K Sell
627
-593
-49% -$47.5K ﹤0.01% 1844
2021
Q3 		$105 Hold
1,220
– – ﹤0.01% 1676
2021
Q2 		$136 Buy
1,220
+1,042
+585% +$100K ﹤0.01% 1557
2021
Q1 		$20 Sell
178
-419
-70% -$55.1K ﹤0.01% 2134
2020
Q4 		$63K Sell
597
-255
-30% -$33.9K ﹤0.01% 1920
2020
Q3 		$119K Sell
852
-362
-30% -$75.5K ﹤0.01% 1491
2020
Q2 		$393K Buy
1,214
+1,120
+1,191% +$180K ﹤0.01% 1105
2020
Q1 		$8K Buy
+94
New +$5.79K ﹤0.01% 1888
2017
Q4 		– Sell
-1,217
Closed -$93K – 1845
2017
Q3 		$93K Buy
+1,217
New +$90.6K ﹤0.01% 1384

Other funds holding INO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nisa Investment Advisors's INO Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 361 shares — an estimated $735 sold.

Nisa Investment Advisors first reported a position in INO in Q3 2017 and held it in 18 quarters. The position peaked at $393K in Q2 2020. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 361 Inovio Pharmaceuticals shares in Q3 2025, an estimated $735.
  • Nisa Investment Advisors first reported a position in Inovio Pharmaceuticals in Q3 2017 and held it in 18 quarters.
  • Nisa Investment Advisors's Inovio Pharmaceuticals position peaked at $393K in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.